Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
批准号:
8767080
负责人:
ANN M MOORMANN
金额:
$57.57万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-10 至 2019-05-31
关键词:
3 year old5 year old9 year oldAfricaAfrican Burkitt&aposs lymphomaAgeAntigensAreaB lymphoid malignancyB-Cell NeoplasmBurkitt LymphomaCD8B1 geneCell LineageCell SurvivalCellsChildChildhoodCohort StudiesDefectDetectionDevelopmentDiagnosisEnvironmentEpstein-Barr Virus InfectionsEtiologyEventFalciparum MalariaFrequenciesFunctional disorderGene ExpressionHumanHuman Herpesvirus 4IL2RB geneIL7R geneIRF4 geneImmuneImmune responseImmunityImmunologic MonitoringImmunologicsImmunosuppressionIn VitroIncidenceIndividualInfantInfectionInflammatoryInterferon Type IIInterferonsInterleukin-12Interleukin-15Interleukin-2Interleukin-7InterventionKenyaKnowledgeLifeLongitudinal StudiesLymphomagenesisLyticMaintenanceMalariaMalignant Childhood NeoplasmMemoryNuclear AntigensPeptidesPhenotypePrevalencePreventiveRecording of previous eventsReportingRiskSamplingSeminalSeveritiesShapesSpecificityStagingStem cellsT cell differentiationT cell regulationT cell responseT memory cellT-LymphocyteT-Lymphocyte EpitopesT-Lymphocyte SubsetsTNF geneTNFRSF6 geneTestingTherapeuticViralViral AntigensViral load measurementcytokineearly childhoodexperienceimprovedinsightinterleukin-23novelperipheral bloodpreventprospectivepublic health relevanceresearch studyresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The syndemic interaction between Plasmodium falciparum malaria and Epstein-Barr virus (EBV) that predispose children to endemic Burkitt lymphoma (eBL), an EBV-associate B cell tumor and the most prevalent pediatric cancer in Equatorial Africa is not completely understood. Due to the prolonged period between primary EBV infection, compounded by repeated malaria infections, and the presentation of eBL later in childhood, longitudinal studies are required in order to fully understand the cumulative impact of malaria on shaping T cell immunity to EBV in the etiology of eBL. Therefore, this proposal aims to test our central hypothesis that malaria adversely influences the differentiation and survival o EBV-specific T cell responses which results in the loss of T cell control over EBV, thereby setting the stage for lymphomagenesis. This hypothesis will be tested by the following Specific Aims. Aim 1. Determine if the prevalence of T memory stem cells (TSCM) correlates with EBV control in children and if EBV-specific TSCM isolated from children have the capacity to expand when instructed by IL-15 and IL-7. CD4+ and CD8+ T cell subsets will be characterized by expression of memory markers (CD45RA/RO, CCR7, CD27, CD127, and CD95) and functionality (IL-2, TNF-?, IFN-?, CD107a) in a retrospective cohort study of children with divergent malaria exposure histories who have been categorized as EBV controllers or non-controllers. IL-7 and IL-15 stimulation will be used to evaluate the expansion potential of TSCM (CD45RA+, CCR7+, CD27+, CD95+). Aim 2. Evaluate the relationship between malaria-associated pro-inflammatory (IL-12, IL-23, IL-31, IL-33) and regulatory (IL-27, IL-35, IL-37) cytokine levels and the expression of transcription factors regulating T cell differentiation that correlate with EBV control in children. We hypothesize that malaria-induced changes in the cytokine environment will influence expression of transcription factors (IRF4, T-bet, Eomes, Bcl6 and TCF1) and thus influence T cell survival. Aim 3. Determine if malaria co-infection during primary EBV infection has a negative impact on the development of EBV-specific T cells associated with viral control and if this phenotype is progressively altered after repeated malaria
infections. A newly established prospective infant cohort study will allow us to capture pivotal events during primary EBV infection to determine whether concurrent and/or cumulative malaria co-infections alter the cytokine milieu and thereby influence the quality and survival of EBV- specific T cells. Information gained from studying T cell memory in children and the immune regulatory microenvironment governing T cell fate will provide novel mechanistic insights into when and how malaria alters EBV immunosurveillance. Improved understanding of the complexity of T cell regulation and survival that renders children co-infected with EBV and malaria at increased risk for eBL will facilitate the development of preventive and therapeutic strategies for this common childhood cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya
-
批准号:10557171
-
项目类别:
-
资助金额:$98.77万
-
财政年份:2022
-
负责人:ANN M MOORMANN
-
依托单位:
A systems immunology approach to evaluate malaria vaccine performance in endemic regions of Kenya
-
批准号:10347760
-
项目类别:
-
资助金额:$98.77万
-
财政年份:2022
-
负责人:ANN M MOORMANN
-
依托单位:
Enhancing racial and ethnic diversity inCOVID-19 research participation through storytelling (COVIDstory)
-
批准号:10264461
-
项目类别:
-
资助金额:$204.37万
-
财政年份:2020
-
负责人:ANN M MOORMANN
-
依托单位:
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
-
批准号:10381202
-
项目类别:
-
资助金额:$15.82万
-
财政年份:2014
-
负责人:ANN M MOORMANN
-
依托单位:
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
-
批准号:10655570
-
项目类别:
-
资助金额:$56.02万
-
财政年份:2014
-
负责人:ANN M MOORMANN
-
依托单位:
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
-
批准号:10439874
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2014
-
负责人:ANN M MOORMANN
-
依托单位:
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
-
批准号:10264137
-
项目类别:
-
资助金额:$53.34万
-
财政年份:2014
-
负责人:ANN M MOORMANN
-
依托单位:
T Cell Immunity in Endemic Burkitt Lymphoma
-
批准号:7963450
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2008
-
负责人:ANN M MOORMANN
-
依托单位:
T Cell Immunity in Endemic Burkitt Lymphoma
-
批准号:8058626
-
项目类别:
-
资助金额:$45.02万
-
财政年份:2008
-
负责人:ANN M MOORMANN
-
依托单位:
T Cell Immunity in Endemic Burkitt Lymphoma
-
批准号:7632271
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2008
-
负责人:ANN M MOORMANN
-
依托单位:
T Cell Immunity in Endemic Burkitt Lymphoma
-
批准号:8244453
-
项目类别:
-
资助金额:$44.39万
-
财政年份:2008
-
负责人:ANN M MOORMANN
-
依托单位:
Immunologic Studies of Endemic Burkitt's Lymphoma
-
批准号:7082891
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2002
-
负责人:ANN M MOORMANN
-
依托单位:
Immunologic Studies of Endemic Burkitt's Lymphoma
-
批准号:6890001
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2002
-
负责人:ANN M MOORMANN
-
依托单位:
Immunologic Studies of Endemic Burkitt's Lymphoma
-
批准号:6643566
-
项目类别:
-
资助金额:$8.73万
-
财政年份:2002
-
负责人:ANN M MOORMANN
-
依托单位:
Immunologic Studies of Endemic Burkitt's Lymphoma
-
批准号:6465687
-
项目类别:
-
资助金额:$8.45万
-
财政年份:2002
-
负责人:ANN M MOORMANN
-
依托单位:
Immunologic Studies of Endemic Burkitt's Lymphoma
-
批准号:6741484
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2002
-
负责人:ANN M MOORMANN
-
依托单位:
海外基金